Trade Vir Biotechnology ^VIR

Vir Biotechnology (NASDAQ:VIR) Director Sells $30,240.00 in Stock - Daily Political

Reviewing Beam Therapeutics (NASDAQ:BEAM) & Vir Biotechnology (NASDAQ:VIR) - Stock Observer

Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Vir Biotechnology (VIR)

VIR Maintained by Leerink Partners -- Price Target Raised to $21

Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $21.00

Leerink Partners Forecasts Strong Price Appreciation for Vir Biotechnology (NASDAQ:VIR) Stock - Daily Political

Insider Sell: Brent Sabatini Sells Shares of Vir Biotechnology Inc (VIR)

Insider Sell: Janet Napolitano Sells 3,200 Shares of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Average Rating of "Moderate Buy" from Analysts

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Analysts

UBS Group AG Purchases 203,203 Shares of Vir Biotechnology, Inc. $VIR

Assessing Vir Biotechnology (VIR) Valuation After Hepatitis Delta Data Update And Astellas Oncology Partnership

VIR: Vir Biotechnology Prepares to Present Trial Data at EASL Congress 2026

Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Million

Vanguard Group Inc. Reduces Stock Position in Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc at Bank of America Global Healthcare Conference Transcript

Q2 EPS Estimates for Vir Biotechnology Cut by HC Wainwright - Stock Observer

Vir Biotechnology, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next - Simply Wall St News

Vir Biotechnology (NASDAQ:VIR) Downgraded by Wall Street Zen to Sell - Stock Observer

A Look At Vir Biotechnology (VIR) Valuation After The Astellas Partnership And Pipeline Progress

Vir Biotechnology (NASDAQ:VIR) Downgraded to "Sell" Rating by Wall Street Zen

Vir Biotechnology (NASDAQ:VIR) Releases Quarterly Earnings Results, Misses Expectations By $0.84 EPS - Stock Observer

Vir Biotechnology Q1 Earnings Call Highlights

Insider Selling: Vir Biotechnology (NASDAQ:VIR) Director Sells $221,100.00 in Stock - Stock Observer

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

AI Podcast: Stock Market Melt-Up Potential? Examining the Bull Run

AI Podcast: Does the Gold-Platinum Ratio Signal Stock Market Risk?

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk